If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giovanni Martinelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia

Cerchione, C., Martinelli, G., Pedatella, S., De Nisco, M., Pugliese, N., Manfra, M., Marra, N., Ronconi, S., De Giorgi, U., Altini, M., Simonetti, G., Di Rorà, A. G. L., Bravaccini, S., Catalano, L., Dora Iula, V., Pagano, F., Picardi, M., Bolognese, A., Pane, F. & Martinelli, V., Jan 1 2020, In : Anti-Cancer Drugs. 31, 1, p. 67-72 6 p.

Research output: Contribution to journalArticle

  • Aneuploidy: Cancer strength or vulnerability?

    Simonetti, G., Bruno, S., Padella, A., Tenti, E. & Martinelli, G., Jan 1 2019, In : International Journal of Cancer. 144, 1, p. 8-25 18 p.

    Research output: Contribution to journalReview article

  • Concurrent chromothripsis events in a case of TP53 depleted acute myeloid leukemia with myelodysplasia-related changes

    Tolomeo, D., L'Abbate, A., Lonoce, A., D'Addabbo, P., Miccoli, M. F., Lo Cunsolo, C., Iuzzolino, P., Palumbo, O., Carella, M., Racanelli, V., Mazza, T., Ottaviani, E., Martinelli, G., Macchia, G. & Storlazzi, C. T., 2019, In : Cancer genetics. 237, p. 63-68 6 p.

    Research output: Contribution to journalArticle

    Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML

    Perl, A. E., Martinelli, G., Cortes, J. E., Neubauer, A., Berman, E., Paolini, S., Montesinos, P., Baer, M. R., Larson, R. A., Ustun, C., Fabbiano, F., Erba, H. P., Di Stasi, A., Stuart, R., Olin, R., Kasner, M., Ciceri, F., Chou, W. C., Podoltsev, N., Recher, C. & 11 others, Yokoyama, H., Hosono, N., Yoon, S. S., Lee, J. H., Pardee, T., Fathi, A. T., Liu, C., Hasabou, N., Liu, X., Bahceci, E. & Levis, M. J., Oct 31 2019, In : New England Journal of Medicine. 381, 18, p. 1728-1740 13 p.

    Research output: Contribution to journalArticle

  • GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

    Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., De Fabritiis, P., Storti, G., Salutari, P., Lanza, F., Martinelli, G., Luppi, M., Mazza, P., Martelli, M. P., Cuneo, A., Albano, F., Fabbiano, F., Tafuri, A., Chierichini, A., Tieghi, A. & 17 others, Fracchiolla, N. S., Capelli, D., Foà, R., Alati, C., Sala, E. L., Fazi, P., Vignetti, M., Maurillo, L., Buccisano, F., Del Principe, M. I., Irno-Consalvo, M., Ottone, T., Lavorgna, S., Voso, M. T., Lo-Coco, F., Arcese, W. & Amadori, S., Sep 19 2019, In : Blood. 134, 12, p. 935-945 11 p.

    Research output: Contribution to journalArticle